Search results
Zacks Investment Ideas feature highlights: Hims & Hers Health and Ero Copper
Zacks via Yahoo News· 3 weeks agoFor Immediate Release Chicago, IL – July 12, 2024 – Today, Zacks Investment Ideas feature highlights...
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo News· 3 weeks agoHims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks....
Are Medical Stocks Lagging Hims & Hers Health (HIMS) This Year?
Zacks via Yahoo News· 3 weeks agoInvestors interested in Medical stocks should always be looking to find the best-performing...
3 Companies Set to Positively Surprise this Earnings Season
Zacks via Yahoo News· 3 weeks agoEarnings season has arrived, with Friday’s big bank results shifting the period into a much higher...
Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?
Zacks via Yahoo News· 4 weeks agoHims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness...
Hims & Hers Health, Inc. (HIMS) Flat As Market Sinks: What You Should Know
Zacks via Yahoo News· 1 month agoThe most recent trading session ended with Hims & Hers Health, Inc. (HIMS) standing at $22.15,...
HIMS Stock Tumbles: Here's Why It's a Buy Right Now
Zacks via Yahoo News· 1 month agoHims & Hers Health (HIMS) has been one of my top stocks to buy in 2024, as it has a fantastic business model, high sales growth and a top Zacks Rank. I...
Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?
Zacks via Yahoo News· 1 month agoLaboratory Corporation of America Holdings LH, or Labcorp’s, focused efforts in the high-growth...
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Zacks via Yahoo News· 1 month agoValneva SE VALN, a specialty vaccine company, has achieved a significant milestone with the approval...
Zacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health Catalyst
Zacks via Yahoo News· 2 months agoFor Immediate Release Chicago, IL – May 29, 2024 – Today, Zacks Equity Research discusses Hims &...